Blockade of protein kinase A (PKA) localization augments the trafficking and anti-tumor efficacy of adoptively transferred chimeric antigen receptor-expressing T cells

被引：0
|
作者：
Newick, Kheng
O'Brien, Shaun
Sun, Jing
Kapoor, Veena
Maceyko, Steve
Lo, Albert
Pure, Ellen
Moon, Ed K.
Albelda, Steven M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.TME16-B27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B27
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Current Challenges and Potential Strategies for Designing a New Generation of Chimeric Antigen Receptor-T cells with High Anti-tumor Activity in Solid Tumors
    Dilara Sahan Khankishiyev
    Gamze Gulden
    Berranur Sert
    Cihan Tastan
    Current Tissue Microenvironment Reports, 2023, 4 (1): : 1 - 16
  • [42] Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells
    Xing, Haiyan
    Yang, Xue
    Xu, Yingxi
    Tang, Kejing
    Tian, Zheng
    Chen, Zhaoqi
    Zhang, Yu
    Xue, Zhenya
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    CYTOTHERAPY, 2021, 23 (09) : 810 - 819
  • [43] Enhance anti-lung tumor efficacy of chimeric antigen receptor-T cells by ectopic expression of C?C motif chemokine receptor 6
    Jin, Liyuan
    Cao, Lei
    Zhu, Yingjie
    Cao, Jiani
    Li, Xiaoyan
    Zhou, Jianxia
    Liu, Bing
    Zhao, Tongbiao
    SCIENCE BULLETIN, 2021, 66 (08) : 803 - 812
  • [44] Inclusion of a Dap10 costimulatory domain enhances anti-tumor efficacy of chimeric PD1-expressing T cells in multiple types of solid tumors
    Barber, Amorette E.
    Parriott, Geoffrey
    Crean, Shane
    Kintz, Hailey
    CANCER RESEARCH, 2018, 78 (13)
  • [45] INCLUSION OF A DAP10 COSTIMULATORY DOMAIN ENHANCES ANTI-TUMOR EFFICACY OF CHIMERIC PD1EXPRESSING T CELLS IN MULTIPLE TYPES OF SOLID TUMORS
    Barber, Amorette
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A64 - A65
  • [46] Chimeric antigen receptor (CAR) T cells incorporating linker and/or transmembrane domains derived from TNFRSF19 demonstrate superior anti-tumor activity
    Xiong, Ying
    Wu, Darong
    Dropulic, Boro
    Orentas, Rimas
    Schneider, Dina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [47] FINE-TUNING OF CD28 SIGNALING MOTIFS INCREASES ANTI-TUMOR ACTIVITY AND PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS
    Guedan, S.
    Posey, A.
    Wing, A.
    Casado-Medrano, V.
    Shaw, C.
    Young, R. M.
    June, C. H.
    HUMAN GENE THERAPY, 2018, 29 (11) : A10 - A11
  • [48] In vivo anti-tumor activity of murine hematopoietic stem cells expressing a p185HER2-specific chimeric T-cell receptor gene
    MICHAEL S FRIEDMAN
    MARIANNE T HUBEN
    JENNIFER FULLER
    ALFRED E CHANG
    JAMES J MULE
    KEVIN T MCDONAGH
    Journal of Microbiology and Immunology, 2006, (02) : 117 - 124
  • [49] CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival
    Nie, Siyue
    Song, Yujie
    Hu, Kun
    Zu, Wei
    Zhang, Fengjiao
    Chen, Lixia
    Ma, Qiang
    Zhou, Zishan
    Jiao, Shunchang
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [50] Combined 4-1BB and ICOS co-stimulation improves anti-tumor efficacy and persistence of dual anti-CD19/CD20 chimeric antigen receptor T cells
    Wang, Ying
    Zhong, Kailun
    Ke, Jun
    Chen, Xi
    Chen, Yi
    Shu, Wangyun
    Chen, Chunhuan
    Hu, Shan
    Sun, Xiaoke
    Huang, Haibin
    Luo, Chong
    Liu, Lifang
    Yang, Jiaming
    Zhang, Yongke
    Zhi, Huijun
    CYTOTHERAPY, 2021, 23 (08) : 715 - 723
12345